Contact
William H. Frishman, M.D., is an internist and cardiologist with a research interest in cardiovascular pharmacology, clinical epidemiology, and geriatrics. Dr. Frishman has authored and co-authored more than 900 original articles, reviews, and book chapters. He has also edited, co-edited, authored, and co-authored twelve full-length textbooks, including the major text Cardiovascular Pharmacotherapeutics (McGraw-Hill), now in its second edition. Dr. Frishman published three books: Complementary and Integrative Therapies for Cardiovascular Disease (Elsevier 2005), Cardiovascular Regeneration and Stem Cell Therapy (Blackwell Futura, 2007), and Hypertension: A Clinical Guide (Lippincott, 2007). He is also the supplements editor for the American Journal of Medicine and a co-editor of the journal Cardiology in Review and the Yearbook of Medicine.
Education
- M.D., Boston University School of Medicine
Areas of Expertise
- Cardiovascular Pharmacology
- Clinical Epidemiology
- Geriatrics
Honors and Awards
- Teaching Scholar Award of the American Heart Association
- Preventative Cardiology Academic Award from the National Heart, Lung and Blood Institute
- Distinguished Teacher Award, Alpha Omega Alpha National Medical Honor Society
Research
Dr. Frishman has served as a principal investigator in multiple NIH-funded studies, including the "Systolic Hypertension in the Elderly" (SHEP) Trial, the "Studies of Left Ventricular Dysfunction" (SOLVD), the "Women's Health Initiative Trial" (WHI), and the "Bronx Longitudinal Aging Study."
Publications
- Macanian J, Frishman WH. "GLP-1 RAs in Substance Use Disorders: Emerging Evidence and Future Directions." Cardiology in review, (), (2026) . doi: 10.1097/CRD.0000000000001319
- Egli C, Frishman WH, Aronow WS, et. al. "The Temporal Dissociation of Vascular Leak and Myocardial Dysfunction in Dengue: Pathophysiology, Diagnostic Challenges, and Implications for Phase-Specific Management." Cardiology in review, (), (2026) . doi: 10.1097/CRD.0000000000001326
- Gera P, Frishman WH, Aronow WS, et. al. "From Adipose Tissue to the Heart: Leptin, Exercise, and Cardiovascular Risk in Women." Cardiology in review, (), (2026) . doi: 10.1097/CRD.0000000000001335
- Agrawal SP, Lussier A, Patel DS, et. al. "Cardiac Biomarkers and Multimodality Imaging in Surveillance During Oncologic Therapy: An Integrated Approach to Cardio-Oncology." Cardiology in review, (), (2026) . doi: 10.1097/CRD.0000000000001334
- Abomohsen M, Mohamed AE, Elkasaby MH, et. al. "Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Pre-Existing Permanent Pacemaker or Implantable Cardioverter-Defibrillator: A Nationwide Propensity-Matched Analysis." Cardiology in review, (), (2026) . doi: 10.1097/CRD.0000000000001336
- Furhang D, Frishman WH, Aronow WS, et. al. "Cardiovascular Effects and Clinical Outcomes Associated With Electronic Cigarette Use: A Narrative Review." Cardiology in review, (), (2026) . doi: 10.1097/CRD.0000000000001324
- Thukral J, Sindhwani N, Khan K, et. al. "Pre-emptive and Prophylactic Strategies to Prevent Cardiovascular and Neurotoxicity in Chimeric Antigen Receptor T-Cell Therapy: The Role of Tocilizumab, Anakinra, and Cytokine-Targeted Interventions." Cardiology in review, (), (2026) . doi: 10.1097/CRD.0000000000001327
